Activity
|
Title
|
Sponsor
|
Type
|
Date/ Time
|
1
|
* ! Bayesian Methods in Cancer Research
|
Biopharmaceutical Section, Section on Bayesian Statistical Science, ENAR, WNAR, Biometrics Section
|
Invited
Papers
|
08/07/2005
2:00 PM to
3:50 PM
|
10
|
* ! Statistical Development in Cancer Screening and Early Detection
|
ENAR, Biopharmaceutical Section, WNAR, Biometrics Section
|
Invited
Papers
|
08/07/2005
2:00 PM to
3:50 PM
|
15
|
* ! Statistical Issues in the Evaluation of Therapeutic Cardiovascular Devices
|
Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/07/2005
2:00 PM to
3:50 PM
|
34
|
* ! Microarray & Genomics
|
Biopharmaceutical Section, ENAR, Section on Statistical Graphics, Biometrics Section, Biometrics Section
|
Contributed
Papers
|
08/07/2005
2:00 PM to
3:50 PM
|
42
|
* Integrating Multiple Sources of Genomic Data
|
Biometrics Section, ENAR, Biopharmaceutical Section, WNAR
|
Invited
Papers
|
08/07/2005
4:00 PM to
5:50 PM
|
53
|
ROC Methods in Diagnostic Device Evaluation
|
Section on Statistics in Epidemiology, Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/07/2005
4:00 PM to
5:50 PM
|
57
|
* Testing Multiple and/or Secondary Hypotheses in Clinical Trials
|
Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/07/2005
4:00 PM to
5:50 PM
|
67
|
General Methodology
|
Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/07/2005
4:00 PM to
5:50 PM
|
74
|
Contributed Poster Session 1
|
Section on Teaching Statistics in the Health Sciences, General Methodology, Section on Nonparametric Statistics, ENAR, Biometrics Section, Biopharmaceutical Section, Business and Economics Statistics Section, Section on Statistical Education, Section on Statistics and the Environment, Section on Statistics in Epidemiology, Section on Government Statistics
|
Contributed
Posters
|
08/07/2005
8:00 PM to
9:50 PM
|
84
|
* ! Pharmacogenomics
|
Biopharmaceutical Section, ENAR, WNAR, Biometrics Section
|
Invited
Papers
|
08/08/2005
8:30 AM to
10:20 AM
|
85
|
* ! Recent Innovations in Clinical Trial Design
|
ENAR, Biopharmaceutical Section, WNAR, Biometrics Section
|
Invited
Papers
|
08/08/2005
8:30 AM to
10:20 AM
|
90
|
* ! Statistical Issues in Contraceptive Devices
|
Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/08/2005
8:30 AM to
10:20 AM
|
91
|
* Optimal Experimental Design
|
General Methodology, Biometrics Section, Biopharmaceutical Section
|
Topic Contributed
Papers
|
08/08/2005
8:30 AM to
10:20 AM
|
92
|
* ! Recent Development in Bayesian Methods with Missing Data
|
Section on Bayesian Statistical Science, Section on Statistics in Epidemiology, ENAR, Biometrics Section, WNAR, Biopharmaceutical Section
|
Topic Contributed
Papers
|
08/08/2005
8:30 AM to
10:20 AM
|
100
|
* ! Analysis of Time-To-Event Data
|
Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/08/2005
8:30 AM to
10:20 AM
|
102
|
* ! Bayesian Modeling and Analysis of Medical and Environmental Data
|
Section on Bayesian Statistical Science, WNAR, ENAR, Section on Statistics in Epidemiology, Biopharmaceutical Section, Section on Statistics and the Environment, Biometrics Section
|
Contributed
Papers
|
08/08/2005
8:30 AM to
10:20 AM
|
118
|
* ! Bayesian Techniques in Functional Genomics
|
Section on Bayesian Statistical Science, ENAR, Biopharmaceutical Section, WNAR, Biometrics Section
|
Invited
Papers
|
08/08/2005
10:30 AM to
12:20 PM
|
120
|
* Importance of "P-values" in Drug Approval Process - Pros and Cons
|
Biopharmaceutical Section, Section on Statistical Education, WNAR
|
Invited
Papers
|
08/08/2005
10:30 AM to
12:20 PM
|
124
|
* Analysis of Responder Data
|
Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/08/2005
10:30 AM to
12:20 PM
|
138
|
* QT and Randomization Issues
|
Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/08/2005
10:30 AM to
12:20 PM
|
140
|
* Issues in Study Design
|
General Methodology, Biopharmaceutical Section, Section on Bayesian Statistical Science
|
Contributed
Papers
|
08/08/2005
10:30 AM to
12:20 PM
|
149
|
Biopharmaceutical Section Roundtable Luncheons (Fee Event)
|
Biopharmaceutical Section
|
Luncheons
Roundtable Lnch
|
08/08/2005
12:30 PM to
1:50 PM
|
176
|
* ICH-E5 Application: To Date and the Future
|
Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/08/2005
2:00 PM to
3:50 PM
|
184
|
Multiple Analytes and Multiple Assays in Diagnostic Medicine
|
Section on Statistics in Epidemiology, Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/08/2005
2:00 PM to
3:50 PM
|
189
|
* ! Survival Analysis and Risk Assessment
|
Biometrics Section, Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/08/2005
2:00 PM to
3:50 PM
|
192
|
* Issues in Clinical Trials
|
WNAR, Biopharmaceutical Section
|
Contributed
Papers
|
08/08/2005
2:00 PM to
3:50 PM
|
200
|
Contributed Poster Session 3
|
General Methodology, ENAR, Biometrics Section, Biopharmaceutical Section, Business and Economics Statistics Section, Section on Statistics and the Environment, Section on Statistics in Epidemiology
|
Contributed
Posters
|
08/08/2005
2:00 PM to
3:50 PM
|
200615
|
Biopharmaceutical Section Executive Committee Meeting (Closed)
|
Biopharmaceutical Section
|
Other
Cmte/Business
|
08/09/2005
7:30 AM to
11:30 AM
|
210
|
* ! Statistical Issues and Methodologies for the New Biomolecular Technology Age
|
Biopharmaceutical Section, WNAR
|
Invited
Papers
|
08/09/2005
8:30 AM to
10:20 AM
|
213
|
* Topics in the Analysis of Longitudinal Data
|
WNAR, Section on Nonparametric Statistics, Social Statistics Section, Section on Survey Research Methods, Section on Statistics in Epidemiology, Biopharmaceutical Section, Biometrics Section
|
Invited
Papers
|
08/09/2005
8:30 AM to
10:20 AM
|
216
|
* ! Recent Developments in Bayesian Survival Analysis
|
Section on Bayesian Statistical Science, Biopharmaceutical Section
|
Invited
Papers
|
08/09/2005
8:30 AM to
10:20 AM
|
218
|
! Innovative Designs and Analysis in Clinical Trials
|
Biometrics Section, Section on Bayesian Statistical Science, Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/09/2005
8:30 AM to
10:20 AM
|
222
|
* Non-inferiority: Paving the Way To the Future
|
Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/09/2005
8:30 AM to
10:20 AM
|
223
|
Imputation and Sensitivity Analysis for Missing Data
|
Biometrics Section, Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/09/2005
8:30 AM to
10:20 AM
|
225
|
Survivor Analysis
|
Biometrics Section, Section on Bayesian Statistical Science, Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/09/2005
8:30 AM to
10:20 AM
|
227
|
* ! Data Augmentation, EM, and Bayesian Methods with Missing Data
|
Section on Bayesian Statistical Science, Section on Statistics in Epidemiology, Biopharmaceutical Section
|
Contributed
Papers
|
08/09/2005
8:30 AM to
10:20 AM
|
230
|
* Analysis of Binary Data
|
Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/09/2005
8:30 AM to
10:20 AM
|
246
|
! Statistical Methods for Cancer Research Data
|
WNAR, Section on Health Policy Statistics, Biopharmaceutical Section, Biometrics Section
|
Invited
Papers
|
08/09/2005
10:30 AM to
12:20 PM
|
257
|
* ! Statistical Issues in Medical Devices Studies
|
Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/09/2005
10:30 AM to
12:20 PM
|
258
|
* ! Bayesian Sample Size and Test
|
Section on Bayesian Statistical Science, Biopharmaceutical Section
|
Topic Contributed
Papers
|
08/09/2005
10:30 AM to
12:20 PM
|
266
|
* PK, Bayesian, and Meta Analysis
|
Biopharmaceutical Section, Section on Bayesian Statistical Science, WNAR
|
Contributed
Papers
|
08/09/2005
10:30 AM to
12:20 PM
|
277
|
Contributed Poster Session 4
|
Section on Quality and Productivity, General Methodology, Section on Nonparametric Statistics, IMS, Section on Bayesian Statistical Science, Biometrics Section, Biopharmaceutical Section, Section on Statistical Computing, Section on Statistical Consulting
|
Contributed
Posters
|
08/09/2005
10:30 AM to
12:20 PM
|
279
|
Biopharmaceutical Section Roundtable Luncheons (Fee Event)
|
Biopharmaceutical Section
|
Luncheons
Roundtable Lnch
|
08/09/2005
12:30 PM to
1:50 PM
|
305
|
* Assessing Information in Clinical Trials to Enable Better Development Decisions
|
Biopharmaceutical Section, WNAR
|
Invited
Papers
|
08/09/2005
2:00 PM to
3:50 PM
|
308
|
! Survival Analysis in Genetics and Genomics
|
ENAR, Section on Nonparametric Statistics, Biopharmaceutical Section, WNAR, Biometrics Section
|
Invited
Papers
|
08/09/2005
2:00 PM to
3:50 PM
|
309
|
Analyzing Quality of Life Data in Clinical Trials
|
Biometrics Section, Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/09/2005
2:00 PM to
3:50 PM
|
312
|
* ! Bayesian Hierarchical Modeling in Biostatistics
|
Section on Bayesian Statistical Science, Section on Statistics in Epidemiology, Biopharmaceutical Section, WNAR, Biometrics Section
|
Topic Contributed
Papers
|
08/09/2005
2:00 PM to
3:50 PM
|
315
|
* ! Statistical Approaches for Benefit Risk Analysis
|
Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/09/2005
2:00 PM to
3:50 PM
|
323
|
Missing Data Issues
|
Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/09/2005
2:00 PM to
3:50 PM
|
330
|
Contributed Poster Session 5
|
Section on Quality and Productivity, Social Statistics Section, General Methodology, Section on Bayesian Statistical Science, Biopharmaceutical Section, Business and Economics Statistics Section, Section on Statistical Computing, Section on Physical and Engineering Sciences
|
Contributed
Posters
|
08/09/2005
2:00 PM to
3:50 PM
|
200476
|
Biopharmaceutical Section Business Meeting
|
Biopharmaceutical Section
|
Other
Cmte/Business
|
08/09/2005
5:30 PM to
7:30 PM
|
345
|
* ! Proof of Concept Strategies: Aspects of Study Design and Analysis
|
Biopharmaceutical Section, Section on Physical and Engineering Sciences, WNAR
|
Invited
Papers
|
08/10/2005
8:30 AM to
10:20 AM
|
349
|
* Interpretation and Inference on Treatment Effects in Multiple - Visit Clinical Trials with Dropouts
|
Biopharmaceutical Section, ENAR, WNAR, Biometrics Section
|
Topic Contributed
Papers
|
08/10/2005
8:30 AM to
10:20 AM
|
361
|
* ! Drug CombinationStudies and Design of Clinical Trials
|
Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/10/2005
8:30 AM to
10:20 AM
|
371
|
Late Breaking Session 2 -- The Cox-2 Inhibitors Story: What Do (Should) We Know and When Do (Should) We Know It--and What Should We Do About It?
|
ASA, ENAR, WNAR, IMS, SSC, Biopharmaceutical Section, Biometrics Section, Section on Risk Analysis
|
Other
Special Presentation
|
08/10/2005
10:30 AM to
12:20 PM
|
381
|
* Going Beyond ITT: Non-compliance in Randomized Trials
|
General Methodology, WNAR, Biopharmaceutical Section, Biometrics Section
|
Invited
Papers
|
08/10/2005
10:30 AM to
12:20 PM
|
388
|
* ! Bayesian Design and Analysis in Medical Devices
|
Section on Bayesian Statistical Science, Biopharmaceutical Section, WNAR, Biometrics Section
|
Topic Contributed
Papers
|
08/10/2005
10:30 AM to
12:20 PM
|
389
|
* Multiple Comparisons in Phase II Studies
|
Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/10/2005
10:30 AM to
12:20 PM
|
390
|
* ! Likelihood, Bayesian and GEE Approaches to Informative Missingness
|
Biometrics Section, Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/10/2005
10:30 AM to
12:20 PM
|
398
|
* Power, Selection Bias, Type I Error, and Measurement Error
|
Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/10/2005
10:30 AM to
12:20 PM
|
408
|
Biopharmaceutical Section Roundtable Luncheons (Fee Event)
|
Biopharmaceutical Section
|
Luncheons
Roundtable Lnch
|
08/10/2005
12:30 PM to
1:50 PM
|
439
|
Calibration Issues in Diagnostic Medicine
|
Section on Statistics in Epidemiology, Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/10/2005
2:00 PM to
3:50 PM
|
444
|
* ! Design and Analysis Issues in Medical Devices Including Postmarket Surveillance
|
Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/10/2005
2:00 PM to
3:50 PM
|
449
|
* Bayesian and Adaptive Methods in Clinical Trials
|
Biopharmaceutical Section, Section on Bayesian Statistical Science, WNAR
|
Contributed
Papers
|
08/10/2005
2:00 PM to
3:50 PM
|
463
|
* Dynamic Allocation of Patients in Clinical Trials
|
Biopharmaceutical Section, ENAR, WNAR, Biometrics Section
|
Invited
Papers
|
08/11/2005
8:30 AM to
10:20 AM
|
464
|
* ! Career Success: Statisticians Collaborating and Thinking Beyond Statistics
|
Committee on Career Development, Section on Statistical Consulting, Biopharmaceutical Section, Business and Economics Statistics Section, Social Statistics Section
|
Invited
Papers
|
08/11/2005
8:30 AM to
10:20 AM
|
470
|
* ! Novel Statistical Genetics Methods that Integrate Genomic and Post-genomic Data
|
WNAR, ENAR, Biopharmaceutical Section, Biometrics Section
|
Invited
Papers
|
08/11/2005
8:30 AM to
10:20 AM
|
483
|
* Topics in Experimental Design
|
Biometrics Section, Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/11/2005
8:30 AM to
10:20 AM
|
487
|
* Sample Size and Power
|
Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/11/2005
8:30 AM to
10:20 AM
|
497
|
Genomic Applications
|
IMS, Biopharmaceutical Section
|
Invited
Papers
|
08/11/2005
10:30 AM to
12:20 PM
|
505
|
* ! Nonrandomized Pharmaceutical Studies
|
Section on Health Policy Statistics, Section on Physical and Engineering Sciences, Business and Economics Statistics Section, Biometrics Section, WNAR, Section on Quality and Productivity, Biopharmaceutical Section
|
Invited
Papers
|
08/11/2005
10:30 AM to
12:20 PM
|
506
|
* Industry Use of SNPs/Haplotypes and Microarrays in Clinical Trials
|
Biopharmaceutical Section, WNAR
|
Invited
Papers
|
08/11/2005
10:30 AM to
12:20 PM
|
509
|
* ! Challenges in Evaluating Enpoints in Cardiovascular Device Trials
|
Biopharmaceutical Section, WNAR
|
Topic Contributed
Papers
|
08/11/2005
10:30 AM to
12:20 PM
|
512
|
* ! Biopharmaceutical Applications and Related Topics in Survival
|
Biometrics Section, Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/11/2005
10:30 AM to
12:20 PM
|
513
|
! Interrater Agreement and Quality of Life
|
Biometrics Section, Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/11/2005
10:30 AM to
12:20 PM
|
522
|
Issues in Preclinical and Dose Raging Trials
|
Biopharmaceutical Section, WNAR
|
Contributed
Papers
|
08/11/2005
10:30 AM to
12:20 PM
|
CE_02C
|
Bayesian Clinical Trial Design - Approaches and Implementation
|
ASA, Section on Bayesian Statistical Science, Biopharmaceutical Section
|
CE Course
|
08/06/2005
8:00 AM to
4:00 PM
|
CE_08C
|
Adaptive Bayesian Clinical Trials
|
ASA, Section on Bayesian Statistical Science, Biopharmaceutical Section
|
CE Course
|
08/07/2005
8:00 AM to
4:00 PM
|
CE_14C
|
Analysis of Clinical Trials: Theory and Applications
|
ASA, Biopharmaceutical Section
|
CE Course
|
08/08/2005
8:00 AM to
4:00 PM
|
- A * preceding a session name means that the session is an applied session.
- A ! preceding a session name means that the session reflects the JSM meeting theme.
|